FIELD: biotechnology.
SUBSTANCE: invention relates to versions of keratin and can be used in medicine when producing a drug having antipyretic, analgesic, antitussive, expectorant, anticonvulsant and antiepileptic action.
EFFECT: invention provides the therapeutic use of keratin, having efficacy in reducing a rise in body temperature in a fever model in SD rats and prolonging the latency of seizures in class III epilepsy in mice; expectorant action in method with release of phenol red in mice; antitussive action in a method for stimulating coughing with an aqueous solution of ammonia in mice and a tendency to reduce the number of writhing in mice and potential analgesic action in acetic acid-induced writhing in ICR mice.
10 cl, 3 dwg, 9 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| KERATIN BD-3, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2815384C1 |
| KERATIN BD-6, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825993C1 |
| KERATIN BD-10, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2823655C1 |
| KERATIN BD-11, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825992C1 |
| KERATIN BD-13, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020 |
|
RU2825991C1 |
| KERATIN BD-4, PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF | 2020 |
|
RU2824893C1 |
| ANTI-αvβ8 ANTIBODIES AND COMPOSITIONS AND THEIR USE | 2019 |
|
RU2812478C2 |
| THERAPEUTIC BIOPREPARATION FOR TREATING HEPATOCELLULAR CARCINOMA | 2014 |
|
RU2739218C2 |
| METHODS OF TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | 2012 |
|
RU2743409C2 |
| MODIFIED DENDRITIC CELLS AND USE THEREOF IN TREATING MALIGNANT TUMOURS | 2017 |
|
RU2711606C2 |
